These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24371223)

  • 1. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.
    Elangovan S; Pathania R; Ramachandran S; Ananth S; Padia RN; Lan L; Singh N; Martin PM; Hawthorn L; Prasad PD; Ganapathy V; Thangaraju M
    Cancer Res; 2014 Feb; 74(4):1166-78. PubMed ID: 24371223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.
    Thangaraju M; Cresci GA; Liu K; Ananth S; Gnanaprakasam JP; Browning DD; Mellinger JD; Smith SB; Digby GJ; Lambert NA; Prasad PD; Ganapathy V
    Cancer Res; 2009 Apr; 69(7):2826-32. PubMed ID: 19276343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.
    Hanson J; Gille A; Zwykiel S; Lukasova M; Clausen BE; Ahmed K; Tunaru S; Wirth A; Offermanns S
    J Clin Invest; 2010 Aug; 120(8):2910-9. PubMed ID: 20664170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.
    Singh N; Gurav A; Sivaprakasam S; Brady E; Padia R; Shi H; Thangaraju M; Prasad PD; Manicassamy S; Munn DH; Lee JR; Offermanns S; Ganapathy V
    Immunity; 2014 Jan; 40(1):128-39. PubMed ID: 24412617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFNγ Induces DNA Methylation-Silenced GPR109A Expression via pSTAT1/p300 and H3K18 Acetylation in Colon Cancer.
    Bardhan K; Paschall AV; Yang D; Chen MR; Simon PS; Bhutia YD; Martin PM; Thangaraju M; Browning DD; Ganapathy V; Heaton CM; Gu K; Lee JR; Liu K
    Cancer Immunol Res; 2015 Jul; 3(7):795-805. PubMed ID: 25735954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes.
    Li X; Millar JS; Brownell N; Briand F; Rader DJ
    Biochem Pharmacol; 2010 Nov; 80(9):1450-7. PubMed ID: 20655299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A.
    Li G; Deng X; Wu C; Zhou Q; Chen L; Shi Y; Huang H; Zhou N
    J Biol Chem; 2011 Sep; 286(36):31199-212. PubMed ID: 21768093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niacin/β-hydroxybutyrate regulates milk fat and milk protein synthesis
    Chen J; Lin T; Zhang S; Yue X; Liu X; Wu C; Liang Y; Zeng X; Ren M; Chen F; Guan W; Zhang S
    Food Funct; 2023 Mar; 14(6):2642-2656. PubMed ID: 36866679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis.
    Bosch A; Bertran SP; Lu Y; Garcia A; Jones AM; Dawson MI; Farias EF
    Breast Cancer Res; 2012 Aug; 14(4):R121. PubMed ID: 22920668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.
    Benyó Z; Gille A; Kero J; Csiky M; Suchánková MC; Nüsing RM; Moers A; Pfeffer K; Offermanns S
    J Clin Invest; 2005 Dec; 115(12):3634-40. PubMed ID: 16322797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.
    Felizardo RJF; de Almeida DC; Pereira RL; Watanabe IKM; Doimo NTS; Ribeiro WR; Cenedeze MA; Hiyane MI; Amano MT; Braga TT; Ferreira CM; Parmigiani RB; Andrade-Oliveira V; Volpini RA; Vinolo MAR; Mariño E; Robert R; Mackay CR; Camara NOS
    FASEB J; 2019 Nov; 33(11):11894-11908. PubMed ID: 31366236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy.
    Gambhir D; Ananth S; Veeranan-Karmegam R; Elangovan S; Hester S; Jennings E; Offermanns S; Nussbaum JJ; Smith SB; Thangaraju M; Ganapathy V; Martin PM
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2208-17. PubMed ID: 22427566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid.
    Pike NB
    J Clin Invest; 2005 Dec; 115(12):3400-3. PubMed ID: 16322787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis.
    Ingersoll MA; Potteaux S; Alvarez D; Hutchison SB; van Rooijen N; Randolph GJ
    Immunobiology; 2012 May; 217(5):548-57. PubMed ID: 21798616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells.
    Wang N; Guo DY; Tian X; Lin HP; Li YP; Chen SJ; Fu YC; Xu WC; Wei CJ
    Gen Comp Endocrinol; 2016 Oct; 237():98-108. PubMed ID: 27570060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin stimulates adiponectin secretion through the GPR109A receptor.
    Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential.
    Gaidarov I; Chen X; Anthony T; Maciejewski-Lenoir D; Liaw C; Unett DJ
    Cell Signal; 2013 Oct; 25(10):2003-16. PubMed ID: 23770183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
    Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
    PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR109A Expression in the Murine Min6 Pancreatic Beta Cell Line, and Its Relation with Glucose Metabolism and Inflammation.
    Yang S; Li X; Wang N; Yin G; Ma S; Fu Y; Wei C; Chen Y; Xu W
    Ann Clin Lab Sci; 2015; 45(3):315-22. PubMed ID: 26116596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.